BioSpace News Archive

Tarveda Therapeutics, a clinical stage biopharmaceutical company discovering and developing a new class of potent and selective miniature drug conjugates (Pentarins®) for the treatment of patients with a wide range of solid tumors today announced that Drew Fromkin, President and Chief Executive Officer, will present at the 11th Annual Biotech Showcase, occurring January 7-9, 2019 at the Hilton Union Square in San Francisco.

Multi-year research collaboration funded by Vertex using Arbor’s proprietary research platform to enhance efforts in developing gene-editing therapies in five diseases

A Phase II study of Namodenoson is enrolling patients for the treatment of NAFLD/NASH

Takeda Pharmaceutical Company Limited is planning to evaluate the application of recently licensed Humabodies from Crescendo for the development of novel CAR-T therapeutics.

Veteran clinical development professional Michael Detke, M.D., Ph.D., has been appointed Chief Medical Officer and Chris Lowe, a longtime life sciences finance expert, is now the company’s Chief Financial Officer

It is expected that the Scheme will become effective, and that closing of the Acquisition will take place, on January 8, 2019

Dance Biopharm Holdings Inc. (“Dance”), a privately-held biotechnology company focused on the development of novel soft mist inhalable formulations of biologics currently available as injections, announces significant 2018 milestones as it prepares to host investor meetings around the J.P. Morgan Healthcare Conference January 7-10, 2019

Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO), (“Onxeo” or “the Company”), a clinical-stage biotechnology company specializing in the development of innovative drugs in oncology, in particular against rare or resistant cancers, today announces the identification of predictive biomarkers for AsiDNA™, its first-in-class non-targeted DNA Damage Response (DDR) inhibitor, which enables personalized medicine approaches.

“I desired a means to verify unknown civil war descendants of their deceased veterans and was also engaged in genealogy family research projects,” said an inventor from Bedford, Texas. “This inspired me to develop a means to verify an individual’s heritage.”

The new location will become the organization’s largest social enterprise pharmacy